Start Your Risk-Free Trial

Insulin Glargine — Discount Pricing

Insulin Glargine is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.

Insulin Glargine Pricing

Pricing typePrice
TheDrugClubDiscount pricing may be available
Typical Retail$299.99

Discount pricing may be available; confirm the price with the dispensing pharmacy.

About Insulin Glargine

Insulin Glargine is a prescription medication. Ask your doctor if Insulin Glargine is right for you.

Conditions Treated with Insulin Glargine

How to Check Insulin Glargine Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available discount pricing

Insulin Glargine at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Type 2 Diabetes Mellitus

Other medications in Diabetes & Metabolism

About Insulin Glargine

Insulin glargine is a vital medication for many living with diabetes, providing long-lasting blood sugar control. At TheDrugClub, we believe essential medications should be affordable. Discover how our members can receive their insulin glargine with a $0 co-pay and the convenience of free home delivery, making managing your health simpler and more budget-friendly.

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Insulin Glargine is approved for (FDA label)

BASAGLAR ® is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. BASAGLAR ® is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use : Not recommended for treating diabetic ketoacidosis. ( 1 ) Limitations of Use BASAGLAR is not recommended for the treatment of diabetic ketoacidosis.

Source: Read the full FDA label on DailyMed. Label effective date: June 16, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial